Whitnell & Co’s Tenet Healthcare THC Stock Holding History

Whitnell & Co’s Portfolio THC Stock Details THC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q3	–	Sell	-274	Closed	-$13K	–	366
2013 Q2	$13K	Buy	+274	New	+$12.3K	0.01%	262

Other funds holding THC

GCM

Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

LCOV

London Company of Virginia Richmond, Virginia $17.5B AUM 29.92% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Samlyn Capital New York $6.14B AUM 42.05% 1-Year Est. Return

Whitnell & Co's THC Position: Q3 2013 in Review

Whitnell & Co sold out of Tenet Healthcare (THC) in Q3 2013, closing a stake of 274 shares — an estimated $13K sold.

Whitnell & Co first reported a position in THC in Q2 2013 and held it in 1 quarter. The position peaked at $13K in Q2 2013. 270 funds tracked by Wall St. Rank hold THC as of Q3 2013.

Whitnell & Co reported no remaining Tenet Healthcare position as of Q3 2013 after selling out during the quarter.
Whitnell & Co sold 274 Tenet Healthcare shares in Q3 2013, an estimated $13K.
Whitnell & Co first reported a position in Tenet Healthcare in Q2 2013 and held it in 1 quarter.
Whitnell & Co's Tenet Healthcare position peaked at $13K in Q2 2013.
270 funds tracked by Wall St. Rank held Tenet Healthcare as of Q3 2013.

Based on Whitnell & Co's 13F filing for Q3 2013, filed 12 Nov 2013.